This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
iCell Gene Therapeutics
Drug Names(s): ICGCN 1, ICGCN-1
Description: Chimeric antigen receptor engineered T-cells properly-matched allogeneic cells engineered to express an undisclosed scFV anibody domain.
Additional information available to subscribers only: